UBS AM’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-76,551
| Closed | -$237K | – | 2701 |
|
|
2024
Q4 | $237K | Buy |
76,551
+1,249
| +2% | +$3.86K | ﹤0.01% | 2629 |
|
|
2024
Q3 | $580K | Sell |
75,302
-3,420
| -4% | -$26.3K | ﹤0.01% | 2607 |
|
|
2024
Q2 | $675K | Buy |
78,722
+66,522
| +545% | +$571K | ﹤0.01% | 2546 |
|
|
2024
Q1 | $96.9K | Hold |
12,200
| – | – | ﹤0.01% | 2494 |
|
|
2023
Q4 | $121K | Hold |
12,200
| – | – | ﹤0.01% | 2519 |
|
|
2023
Q3 | $137K | Sell |
12,200
-20,797
| -63% | -$234K | ﹤0.01% | 2546 |
|
|
2023
Q2 | $130K | Hold |
32,997
| – | – | ﹤0.01% | 2616 |
|
|
2023
Q1 | $130K | Buy |
32,997
+20,797
| +170% | +$82.1K | ﹤0.01% | 2616 |
|
|
2022
Q4 | $88.5K | Hold |
12,200
| – | – | ﹤0.01% | 2500 |
|
|
2022
Q3 | $44.2K | Hold |
12,200
| – | – | ﹤0.01% | 2717 |
|
|
2022
Q2 | $55.3K | Hold |
12,200
| – | – | ﹤0.01% | 2669 |
|
|
2022
Q1 | $92.5K | Hold |
12,200
| – | – | ﹤0.01% | 2745 |
|
|
2021
Q4 | $133K | Buy |
+12,200
| New | +$133K | ﹤0.01% | 2803 |
|